Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
Abroad (travel likely)RecruitingPHASE2
Conditions
Primary Central Nervous System Lymphoma · Secondary Central Nervous System Lymphoma · Relapsed Cancer · Refractory Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Study leads
Yuliya Linhares, M.D.
Principal Investigator
Miami Cancer Institute at Baptist Health, Inc.